Home/Filings/4/0001493152-18-001029
4//SEC Filing

Anderson David Evander 4

Accession 0001493152-18-001029

CIK 0000764195other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 2:38 PM ET

Size

6.2 KB

Accession

0001493152-18-001029

Insider Transaction Report

Form 4
Period: 2018-01-23
Anderson David Evander
Chief Scientific Officer
Transactions
  • Award

    Option (Right to Buy Common Shares)

    2018-01-23+100,000100,000 total
    Exercise: $4.19Exp: 2028-01-23Common Shares (100,000 underlying)
Footnotes (2)
  • [F1]The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 23, 2018 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 23, 2018 (the "Option Agreement"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date.
  • [F2]The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.

Documents

1 file

Issuer

VBI Vaccines Inc/BC

CIK 0000764195

Entity typeother

Related Parties

1
  • filerCIK 0001616018

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 2:38 PM ET
Size
6.2 KB